syngo US Workplace

Advance Clinical Applications; Anywhere, Anytime

syngo US Workplace
Contact Us

Upgrades & Services
Always Current

syngo® US Workplace, Release 3.5 offers versatile image management and advanced cardiology, vascular, and general imaging. It works with ultrasound studies from a wide range of platforms including select Siemens and non-Siemens platforms.

syngo US Workplace enables you to stay current with the most advanced clinical applications without waiting for the upgrade of your ultrasound systems:

  • Functionality expands over time
  • Advanced analytical tools
  • Cost-effective and efficient

syngo US Workplace 3.5 offers more powerful ultrasound image analysis applications and workflow enhancements in more clinical specialties than ever before:


syngo® Velocity Vector Imaging™ (VVI) technology: An advanced quantitative tool for the 2D assessment of myocardial motion and mechanics. Enables visualization and quantification of data including velocity, strain, strain rate, displacement areas, volumes, ejection fraction, LV Mass, peak and time to peak values from global, segment and localized areas.

syngo® Auto Left Heart (Auto LH): Automatically generates left atrial and left ventriclar volumes and ejection fractions—rapidly and reliably.

syngo® Auto Ejection Fraction (Auto EF): Increases consistency and efficiency by automatically calculating ejection fraction.

syngo® Quantitative Synch Tool technology (QST): An advanced Tissue Doppler application that helps identify and assess cardiac motion and timing issues, quickly and precisely.

syngo® Auto-Tracking Contrast Quantification (ACQ): Uses regions of interest in tissue to generate Time Intensity Curves (TIC) for quantitative assessment of contrast agent* appearance and uptake within tissue over time.

syngo® Mitral Valve Assessment (MVA): Ènables a detailed assessment of mitral valve morphology from 3D images for a more accurate and complete diagnosis of pathology, location and size.

syngo® fourSight™ TEE View: Advanced interrogation of cardiac structure and function with integrated 3D transesophageal imaging.

Image Management
syngo® Stress Echo Review: Enables the user to review, analyze and report exercise and pharmacological stress echo examinations with customizable reporting
syngo® US Image Review: 2D image and clip review
syngo® Cardiac Calc Package: Generic and cardiac M-mode, 2D and Doppler measurements. Quick measurements can be saved in a database for statistical analysis and can be imported into the report template
syngo® Cardiac Reporting: Easily document diagnostic findings and create a detailed patient report. Standard report templates are available

Vascular Screening

syngo® Arterial Health Package (AHP):** Semi-automated tool measures carotid intima media thickness (CIMT) with Vascular Age*** and Framingham Risk Factors, and the option to reference normative tables that have been validated and published in peer-reviewed studies.

Radiology and OB/GYN

syngo® Auto-Tracking Contrast Quantification (ACQ): Uses regions of interest to generate Time Intensity Curves (TIC) for quantitative assessment of contrast agent* appearance and uptake within tissue over time.  

Related Products, Services & Resources

*At the time of publication, the U.S. Food & Drug Administration has cleared ultrasound contrast agents only for use in LVO. Check the current regulation for the country in which you are using this system for contrast agent clearance.

** This feature should be utilized according to the ASE Consensus Statement "Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force, Endorsed by the Society for Vascular Medicine”

*** Based on Dr. Jim Stein’s patented algorithm:
Stein, JH, Fraizer, MC, Aeschlimann SE, Nelson-Worel J, McBride PE, Douglas PS. Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessment. Clin Cardiol 2004; 27:388-92. M